Compare Medpace Holdings Inc (MEDP) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Western Digital Corp — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while Western Digital Corp trades at $395.58 (market cap $147.23B). The key difference: Western Digital Corp is far larger — about 8.8× Medpace Holdings Inc's market cap, and Western Digital Corp pays a 0.15% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Western Digital Corp for 37 Days on average.
| MEDP | WDC | |
|---|---|---|
Market Cap | $16.82B | $147.23B |
Volume | 223,093 | 9,341,468 |
Sector | Health | Technology |
52-Week High | $630.19 | $746.23 |
52-Week Low | $393.42 | $113.13 |
Typical Hold Time | 14 Days | 37 Days |
Enterprise Value | $16.44B | $146.70B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Western Digital (WDC) trades at $397.28, down 1.96% amid recent sector volatility. The stock shows strong fundamentals with a 14.61 P/E ratio and impressive 71.97% net income margin, supported by three consecutive quarterly earnings beats. Technical indicators suggest bearish momentum with the price near pivot point support at $397. Recent news highlights competitive pressures from Toshiba's planned HDD production expansion, contributing to the stock's recent decline.
WDC presents a compelling value opportunity with strong profitability metrics and analyst consensus favoring bullish sentiment (72% buy ratings). However, investors face near-term risks from increased competition in AI storage markets and potential margin pressure. The $647.58 consensus price target suggests significant upside potential if the company maintains its competitive positioning and executes on growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
